{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T08:09:33Z","timestamp":1746518973571},"reference-count":40,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,25]]},"DOI":"10.7759\/cureus.28389","type":"journal-article","created":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T13:34:03Z","timestamp":1661434443000},"source":"Crossref","is-referenced-by-count":2,"title":["A Comprehensive Investigation of the Current Subacute Sclerosing Panencephalitis (SSPE) Treatment Options to Improve Patient Quality of Life"],"prefix":"10.7759","author":[{"given":"Ariana","family":"Pritha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanisha N","family":"Medha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravindra K","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1330733","article-title":"The effectiveness of measles-mumps-rubella (MMR) vaccination in the prevention of pediatric hospitalizations for targeted and untargeted infections: a retrospective cohort study","volume":"13","author":"La Torre G","year":"2017","unstructured":"La Torre G, Saulle R, Unim B, Meggiolaro A, Barbato A, Mannocci A, Spadea A. The effectiveness of measles-mumps-rubella (MMR) vaccination in the prevention of pediatric hospitalizations for targeted and untargeted infections: a retrospective cohort study. Hum Vaccin Immunother. 2017, 13:1879-83. 10.1080\/21645515.2017.1330733","journal-title":"Hum Vaccin Immunother"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l2335","article-title":"Measles: Public Health England urges all parents to get their children vaccinated as cases spike","volume":"365","author":"Mahase E","year":"2019","unstructured":"Mahase E. Measles: Public Health England urges all parents to get their children vaccinated as cases spike. BMJ. 2019, 365:l2335. 10.1136\/bmj.l2335","journal-title":"BMJ"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(97)11096-0","article-title":"Retracted: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children","volume":"351","author":"Wakefield A","year":"1998","unstructured":"Wakefield A, Murch S, Anthony A, et al.. Retracted: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. The Lancet. 1998, 351:637-41. 10.1016\/s0140-6736(97)11096-0","journal-title":"The Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.22037\/ijcn.v2i2.459","article-title":"Use of \u0391-Interferon, Amantadin and Isoprinosine in subacute sclerosing panencephalitis (SSPE): comparing the effectiveness","volume":"2","author":"Nasirian A","year":"2008","unstructured":"Nasirian A, Ashrafi MR, Nasrabady SE. Use of \u0391-Interferon, Amantadin and Isoprinosine in subacute sclerosing panencephalitis (SSPE): comparing the effectiveness . Iran J Child Neurol. 2008, 2:27-32. 10.22037\/ijcn.v2i2.459","journal-title":"Iran J Child Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2004.07.003","article-title":"Long-term follow-up of a patient with subacute sclerosing panencephalitis successfully treated with intrathecal interferon alpha","volume":"27","author":"Miyazaki M","year":"2005","unstructured":"Miyazaki M, Nishimura M, Toda Y, Saijo T, Mori K, Kuroda Y. Long-term follow-up of a patient with subacute sclerosing panencephalitis successfully treated with intrathecal interferon alpha. Brain Dev. 2005, 27:301-3. 10.1016\/j.braindev.2004.07.003","journal-title":"Brain Dev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/23120053.2016.1156868","article-title":"Interferon alpha in subacute sclerosing panencephalitis: case report and review of the literature","volume":"31","author":"Moodley K","year":"2015","unstructured":"Moodley K, Bill P, Patel V. Interferon alpha in subacute sclerosing panencephalitis: case report and review of the literature. S Afr J Infect Dis. 2015, 31:130-4. 10.1080\/23120053.2016.1156868","journal-title":"S Afr J Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-5-47","article-title":"Subacute sclerosing panencephalitis: results of the Canadian Paediatric Surveillance Program and review of the literature","volume":"5","author":"Campbell C","year":"2005","unstructured":"Campbell C, Levin S, Humphreys P, Walop W, Brannan R. Subacute sclerosing panencephalitis: results of the Canadian Paediatric Surveillance Program and review of the literature. BMC Pediatr. 2005, 5:47. 10.1186\/1471-2431-5-47","journal-title":"BMC Pediatr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/08830738030180020701","article-title":"Combined treatment with subcutaneous interferon-alpha, oral isoprinosine, and lamivudine for subacute sclerosing panencephalitis","volume":"18","author":"Aydin OF","year":"2003","unstructured":"Aydin OF, Senbil N, Kuyucu N, G\u00fcrer YK. Combined treatment with subcutaneous interferon-alpha, oral isoprinosine, and lamivudine for subacute sclerosing panencephalitis. J Child Neurol. 2003, 18:104-8. 10.1177\/08830738030180020701","journal-title":"J Child Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5692\/clinicalneurol.51.1047","article-title":"Subacute sclerosing panencephalitis (SSPE) (Article in Japanese)","volume":"51","author":"Hosoya M","year":"2011","unstructured":"Hosoya M. Subacute sclerosing panencephalitis (SSPE) (Article in Japanese). Rinsho Shinkeigaku. 2011, 51:1047-50. 10.5692\/clinicalneurol.51.1047","journal-title":"Rinsho Shinkeigaku"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2014.03.001","article-title":"A serial 18-FDG-PET study of a patient with SSPE who had good prognosis by combination therapy with interferon alpha and ribavirin","volume":"18","author":"Ohya T","year":"2014","unstructured":"Ohya T, Yamashita Y, Shibuya I, et al.. A serial 18-FDG-PET study of a patient with SSPE who had good prognosis by combination therapy with interferon alpha and ribavirin. Eur J Paediatr Neurol. 2014, 18:536-9. 10.1016\/j.ejpn.2014.03.001","journal-title":"Eur J Paediatr Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-510x(98)00302-5","article-title":"\u03b1-Interferon and Isoprinosine in adult-onset subacute sclerosing panencephalitis","volume":"162","author":"Gokcil Z","year":"1999","unstructured":"Gokcil Z, Odabasi Z, Demirkaya S, et al.. \u03b1-Interferon and Isoprinosine in adult-onset subacute sclerosing panencephalitis. J Neurol Sci. 1999, 162:62-4. 10.1016\/s0022-510x(98)00302-5","journal-title":"J Neurol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3345\/kjp.2018.06730","article-title":"A long-term subacute sclerosing panencephalitis survivor treated with intraventricular interferon-alpha for 13 years","volume":"62","author":"Kwak M","year":"2019","unstructured":"Kwak M, Yeh HR, Yum MS, Kim HJ, You SJ, Ko TS. A long-term subacute sclerosing panencephalitis survivor treated with intraventricular interferon-alpha for 13 years. Korean J Pediatr. 2019, 62:108-12. 10.3345\/kjp.2018.06730","journal-title":"Korean J Pediatr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/088307380201700911","article-title":"Treatment of subacute sclerosing panencephalitis with interferon-alpha, ribavirin, and inosiplex","volume":"17","author":"Solomon T","year":"2002","unstructured":"Solomon T, Hart CA, Vinjamuri S, Beeching NJ, Malucci C, Humphrey P. Treatment of subacute sclerosing panencephalitis with interferon-alpha, ribavirin, and inosiplex. J Child Neurol. 2002, 17:703-5. 10.1177\/088307380201700911","journal-title":"J Child Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-510x(02)00360-x","article-title":"Interferon therapy-responsive brain metabolic abnormalities in a case of adult-onset subacute sclerosing panencephalitis evaluated by 1H MRS analysis","volume":"207","author":"Takashima H","year":"2003","unstructured":"Takashima H, Eriguchi M, Nakamura T, et al.. Interferon therapy-responsive brain metabolic abnormalities in a case of adult-onset subacute sclerosing panencephalitis evaluated by 1H MRS analysis. J Neurol Sci. 2003, 207:59-63. 10.1016\/s0022-510x(02)00360-x","journal-title":"J Neurol Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2011.01.011","article-title":"Measles-vaccinated Israeli boy with subacute sclerosing panencephalitis","volume":"44","author":"Har-Even R","year":"2011","unstructured":"Har-Even R, Aichenbaum S, Rabey JM, Livne A, Bistritzer T. Measles-vaccinated Israeli boy with subacute sclerosing panencephalitis. Pediatr Neurol. 2011, 44:467-70. 10.1016\/j.pediatrneurol.2011.01.011","journal-title":"Pediatr Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-002-0979-8","article-title":"Early onset and rapidly progressive subacute sclerosing panencephalitis after congenital measles infection","volume":"161","author":"Cruzado D","year":"2002","unstructured":"Cruzado D, Masserey-Spicher V, Roux L, Delavelle J, Picard F, Haenggeli CA. Early onset and rapidly progressive subacute sclerosing panencephalitis after congenital measles infection. Eur J Pediatr. 2002, 161:438-41. 10.1007\/s00431-002-0979-8","journal-title":"Eur J Pediatr"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s1071-9091(99)80008-4","article-title":"Subacute encephalopathy in a 5-year-old boy","volume":"6","author":"Bobele GB","year":"1999","unstructured":"Bobele GB, Bale JFJ. Subacute encephalopathy in a 5-year-old boy. Semin Pediatr Neurol. 1999, 6:168-72. 10.1016\/s1071-9091(99)80008-4","journal-title":"Semin Pediatr Neurol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/s0387-7604(03)00062-7","article-title":"Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan","volume":"25","author":"Tomoda A","year":"2003","unstructured":"Tomoda A, Nomura K, Sheraishi S, et al.. Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan. Brain Dev. 2003, 25:514-7. 10.1016\/s0387-7604(03)00062-7","journal-title":"Brain Dev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2020.05.009","article-title":"Aprepitant in the treatment of subacute sclerosing panencephalitis: a randomized, double-blind, placebo-controlled study","volume":"110","author":"Oncel I","year":"2020","unstructured":"Oncel I, Sancar M, Konuskan B, et al.. Aprepitant in the treatment of subacute sclerosing panencephalitis: a randomized, double-blind, placebo-controlled study. Pediatr Neurol. 2020, 110:59-63. 10.1016\/j.pediatrneurol.2020.05.009","journal-title":"Pediatr Neurol"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.94.15_supplement.4198","article-title":"A potential cure in adult onset subacute sclerosing panencephalitis (4198)","volume":"94","author":"Panda S","year":"2020","unstructured":"Panda S. A potential cure in adult onset subacute sclerosing panencephalitis (4198). Neurology. 2020, 94:","journal-title":"Neurology"},{"key":"ref21","doi-asserted-by":"crossref","DOI":"10.1684\/j.1950-6945.2004.tb00059.x","article-title":"Panayiotopoulos syndrome: video\u2010EEG illustration of a typical seizure","volume":"6","author":"Demirbilek V","year":"2004","unstructured":"Demirbilek V, Dervent A. Panayiotopoulos syndrome: video\u2010EEG illustration of a typical seizure. Epileptic Disorders. 2004, 6:121-4.","journal-title":"Epileptic Disorders"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.24953\/turkjped.2017.03.009","article-title":"The behavior pattern of parents of patients with subacute sclerosing panencephalitis concerning alternative medicine","volume":"59","author":"I\u015f\u0131kay S","year":"2017","unstructured":"I\u015f\u0131kay S. The behavior pattern of parents of patients with subacute sclerosing panencephalitis concerning alternative medicine. Turk J Pediatr. 2017, 59:288-94. 10.24953\/turkjped.2017.03.009","journal-title":"Turk J Pediatr"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2010.07.035","article-title":"Flupirtine may stop the progressive course of subacute sclerosing panencephalitis","volume":"75","author":"Tatli B","year":"2010","unstructured":"Tatli B, Ekici B, Ozmen M. Flupirtine may stop the progressive course of subacute sclerosing panencephalitis. Med Hypotheses. 2010, 75:576-7. 10.1016\/j.mehy.2010.07.035","journal-title":"Med Hypotheses"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/s1059-1311(02)00268-6","article-title":"The use of the ketogenic diet in a patient with subacute sclerosing panencephalitis","volume":"12","author":"Bautista RE","year":"2003","unstructured":"Bautista RE. The use of the ketogenic diet in a patient with subacute sclerosing panencephalitis. Seizure. 2003, 12:175-7. 10.1016\/s1059-1311(02)00268-6","journal-title":"Seizure"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.12747","article-title":"Mesenchymal stem cell application in children with subacute sclerosing panencephalitis","volume":"57","author":"Ku\u015fkonmaz B","year":"2015","unstructured":"Ku\u015fkonmaz B, U\u00e7kan D, Yalnizo\u011flu D, G\u00fcnel M, Karli O\u011fuz K, Konu\u015fkan B, Anlar B. Mesenchymal stem cell application in children with subacute sclerosing panencephalitis. Dev Med Child Neurol. 2015, 57:880-3. 10.1111\/dmcn.12747","journal-title":"Dev Med Child Neurol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/pmj.78.916.63","article-title":"Subacute sclerosing panencephalitis","volume":"78","author":"Garg RK","year":"2002","unstructured":"Garg RK. Subacute sclerosing panencephalitis. Postgrad Med J. 2002, 78:63-70. 10.1136\/pmj.78.916.63","journal-title":"Postgrad Med J"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/v14040733","article-title":"Subacute sclerosing panencephalitis in children: the archetype of non-vaccination","volume":"14","author":"Papetti L","year":"2022","unstructured":"Papetti L, Amodeo ME, Sabatini L, et al.. Subacute sclerosing panencephalitis in children: the archetype of non-vaccination. Viruses. 2022, 14:733. 10.3390\/v14040733","journal-title":"Viruses"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpurol.2020.07.002","article-title":"The impact of COVID-19 on research","volume":"16","author":"Harper L","year":"2020","unstructured":"Harper L, Kalfa N, Beckers GM, et al.. The impact of COVID-19 on research. J Pediatr Urol. 2020, 16:715-6. 10.1016\/j.jpurol.2020.07.002","journal-title":"J Pediatr Urol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01237-5","article-title":"A dangerous measles future looms beyond the COVID-19 pandemic","volume":"27","author":"Durrheim DN","year":"2021","unstructured":"Durrheim DN, Andrus JK, Tabassum S, Bashour H, Githanga D, Pfaff G. A dangerous measles future looms beyond the COVID-19 pandemic. Nat Med. 2021, 27:360-1. 10.1038\/s41591-021-01237-5","journal-title":"Nat Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200948030-00001","article-title":"Sex differences in pharmacokinetics and pharmacodynamics","volume":"48","author":"Soldin OP","year":"2009","unstructured":"Soldin OP, Mattison DR. Sex differences in pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 2009, 48:143-57. 10.2165\/00003088-200948030-00001","journal-title":"Clin Pharmacokinet"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/327647","article-title":"Role of carbamazepine in the symptomatic treatment of subacute sclerosing panencephalitis: a case report and review of the literature","volume":"2013","author":"Ravikumar S","year":"2013","unstructured":"Ravikumar S, Crawford JR. Role of carbamazepine in the symptomatic treatment of subacute sclerosing panencephalitis: a case report and review of the literature. Case Rep Neurol Med. 2013, 2013:327647. 10.1155\/2013\/327647","journal-title":"Case Rep Neurol Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26020427","article-title":"Advances in antiviral therapy for subacute sclerosing panencephalitis","volume":"26","author":"Hashimoto K","year":"2021","unstructured":"Hashimoto K, Hosoya M. Advances in antiviral therapy for subacute sclerosing panencephalitis. Molecules. 2021, 26:427. 10.3390\/molecules26020427","journal-title":"Molecules"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/0887-8994(96)00086-0","article-title":"Carbamazepine and myoclonus in SSPE subacute sclerosing panencephalitis","volume":"14","author":"Hayashi T","year":"1996","unstructured":"Hayashi T, Ichiyama T, Nishikawa M, Furukawa S. Carbamazepine and myoclonus in SSPE subacute sclerosing panencephalitis. Pediatr Neurol. 1996, 14:346. 10.1016\/0887-8994(96)00086-0","journal-title":"Pediatr Neurol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02166-17","article-title":"Cell-to-cell measles virus spread between human neurons Is dependent on hemagglutinin and hyperfusogenic fusion protein","volume":"92","author":"Sato Y","year":"2018","unstructured":"Sato Y, Watanabe S, Fukuda Y, Hashiguchi T, Yanagi Y, Ohno S. Cell-to-cell measles virus spread between human neurons Is dependent on hemagglutinin and hyperfusogenic fusion protein. J Virol. 2018, 92:10.1128\/JVI.02166-17","journal-title":"J Virol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix302","article-title":"Subacute sclerosing panencephalitis: the devastating measles complication that might be more common than previously estimated","volume":"65","author":"Wendorf KA","year":"2017","unstructured":"Wendorf KA, Winter K, Zipprich J, et al.. Subacute sclerosing panencephalitis: the devastating measles complication that might be more common than previously estimated. Clin Infect Dis. 2017, 65:226-32. 10.1093\/cid\/cix302","journal-title":"Clin Infect Dis"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-019-00995-6","article-title":"Inosine pranobex: a key player in the game against a wide range of viral infections and non-infectious diseases","volume":"36","author":"Sliva J","year":"2019","unstructured":"Sliva J, Pantzartzi CN, Votava M. Inosine pranobex: a key player in the game against a wide range of viral infections and non-infectious diseases. Adv Ther. 2019, 36:1878-905. 10.1007\/s12325-019-00995-6","journal-title":"Adv Ther"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.1585","article-title":"Marked atrophic changes of the brain in a patient with subacute sclerosing panencephalitis","volume":"9","author":"Yasin F","year":"2017","unstructured":"Yasin F, Assad S, Nadeem M, Zahid M. Marked atrophic changes of the brain in a patient with subacute sclerosing panencephalitis. Cureus. 2017, 9:e1585. 10.7759\/cureus.1585","journal-title":"Cureus"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2016.02.005","article-title":"Subacute sclerosing panencephalitis presenting as acute cerebellar ataxia and brain stem hyperintensities","volume":"20","author":"Saini AG","year":"2016","unstructured":"Saini AG, Sankhyan N, Padmanabh H, Sahu JK, Vyas S, Singhi P. Subacute sclerosing panencephalitis presenting as acute cerebellar ataxia and brain stem hyperintensities. Eur J Paediatr Neurol. 2016, 20:435-8. 10.1016\/j.ejpn.2016.02.005","journal-title":"Eur J Paediatr Neurol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.12809\/hkmj187470","article-title":"Measles: a disease often forgotten but not gone","volume":"24","author":"Leung AK","year":"2018","unstructured":"Leung AK, Hon KL, Leong KF, Sergi CM. Measles: a disease often forgotten but not gone. Hong Kong Med J. 2018, 24:512-20. 10.12809\/hkmj187470","journal-title":"Hong Kong Med J"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-022-02051-w","article-title":"Pandemic drives largest drop in childhood vaccinations in 30 years","volume":"608","author":"Guglielmi G","year":"2022","unstructured":"Guglielmi G. Pandemic drives largest drop in childhood vaccinations in 30 years. Nature. 2022, 608:253. 10.1038\/d41586-022-02051-w","journal-title":"Nature"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/108081-a-comprehensive-investigation-of-the-current-subacute-sclerosing-panencephalitis-sspe-treatment-options-to-improve-patient-quality-of-life","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T15:48:10Z","timestamp":1727884090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/108081-a-comprehensive-investigation-of-the-current-subacute-sclerosing-panencephalitis-sspe-treatment-options-to-improve-patient-quality-of-life"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,25]]},"references-count":40,"URL":"https:\/\/doi.org\/10.7759\/cureus.28389","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2022,8,25]]}}}